Zhu and colleagues also revealed that exosomal miR-223 derived from hypoxic macrophages could enhance drug resistance in epithelial ovarian cancer cells via the PTEN-PI3K/AKT pathways in vitro and in vivo. This evidence concerns the gene PTEN and ovarian carcinoma.